ZA786739B - Hydantoin derivatives and salts thereof,their syntheses,and intermediates,and pharmaceutical formulations - Google Patents
Hydantoin derivatives and salts thereof,their syntheses,and intermediates,and pharmaceutical formulationsInfo
- Publication number
- ZA786739B ZA786739B ZA786739A ZA786739A ZA786739B ZA 786739 B ZA786739 B ZA 786739B ZA 786739 A ZA786739 A ZA 786739A ZA 786739 A ZA786739 A ZA 786739A ZA 786739 B ZA786739 B ZA 786739B
- Authority
- ZA
- South Africa
- Prior art keywords
- syntheses
- intermediates
- salts
- pharmaceutical formulations
- hydantoin derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5009377 | 1977-12-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA786739B true ZA786739B (en) | 1980-07-30 |
Family
ID=10454631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA786739A ZA786739B (en) | 1977-12-01 | 1978-11-30 | Hydantoin derivatives and salts thereof,their syntheses,and intermediates,and pharmaceutical formulations |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0002259B1 (da) |
JP (1) | JPS5492962A (da) |
AU (1) | AU531493B2 (da) |
DE (1) | DE2862445D1 (da) |
DK (1) | DK543178A (da) |
ZA (1) | ZA786739B (da) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL59065A0 (en) * | 1979-01-18 | 1980-05-30 | Beecham Group Ltd | Hydantoin derivatives,their preparation pharmaceutical compositons containing them |
EP0023083A1 (en) * | 1979-06-27 | 1981-01-28 | Beecham Group Plc | Oxodiazole derivatives, processes for their production and pharmaceutical composition containing them |
US5137904A (en) * | 1989-05-30 | 1992-08-11 | G. D. Searle & Co. | Thiohydantoin inhibitors of collagen-induced and ADP-induced platelet aggregation |
JPH04297461A (ja) * | 1991-03-27 | 1992-10-21 | Otsuka Pharmaceut Factory Inc | 2−チオヒダントイン誘導体 |
IL102548A (en) * | 1991-08-02 | 1998-08-16 | Medivir Ab | Use of painting derivatives in the preparation of drugs for VIH inhibition and treatment of SDIA and new compounds |
US5593993A (en) * | 1991-08-02 | 1997-01-14 | Medivir Ab | Method for inhibition of HIV related viruses |
FR2845384B1 (fr) * | 2002-10-04 | 2004-12-31 | Fournier Lab Sa | Composes derives de la 2-thiohydantoine et leur utilisation en therapeutique |
FR2845383B1 (fr) * | 2002-10-04 | 2004-12-31 | Fournier Lab Sa | Composes derives de la 2-thiohydantoine et leur utilisation en therapeutique |
FR2845385B1 (fr) * | 2002-10-04 | 2004-12-31 | Fournier Lab Sa | Composes derives de la 2-thiohydantoine et leur utilisation en therapeutique |
AU2003279442A1 (en) * | 2002-10-04 | 2004-04-23 | Laboratoires Fournier S.A. | 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes |
EP2299266A1 (en) | 2003-12-19 | 2011-03-23 | The Regents of the University of California | Methods and materials for assessing prostate cancer therapies |
NZ550102A (en) | 2004-02-24 | 2010-10-29 | Univ California | Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives) |
US7709517B2 (en) | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
ES2863798T3 (es) | 2006-03-27 | 2021-10-11 | Univ California | Modulador del receptor de andrógenos para el tratamiento del cáncer de próstata y enfermedades asociadas con el receptor de andrógenos |
RU2449993C2 (ru) | 2006-03-29 | 2012-05-10 | Те Риджентс Оф Те Юниверсити Оф Калифорния | Диарилтиогидантоиновые соединения |
CA2703635C (en) | 2007-10-26 | 2017-06-27 | Michael E. Jung | Diarylhydantoin compounds as androgen receptor modulators |
EP3124481B1 (en) | 2010-02-16 | 2018-03-28 | Aragon Pharmaceuticals, Inc. | Androgen receptor modulators and uses thereof |
KR20210013342A (ko) | 2012-09-26 | 2021-02-03 | 아라곤 파마슈티컬스, 인코포레이티드 | 비전이성 거세 저항성 전립선암 치료용 항안드로겐 |
JOP20200097A1 (ar) | 2013-01-15 | 2017-06-16 | Aragon Pharmaceuticals Inc | معدل مستقبل أندروجين واستخداماته |
TWI726969B (zh) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物 |
JOP20200076A1 (ar) | 2017-10-16 | 2020-04-30 | Aragon Pharmaceuticals Inc | مضادات أندروجين لعلاج سرطان البروستاتا غير النقيلي المقاوم للاستئصال |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB817745A (en) * | 1956-12-14 | 1959-08-06 | Ici Ltd | 2-thiohydantoins |
DE2138225A1 (de) * | 1971-07-30 | 1973-02-08 | Diamalt Ag | Hydantoinderivate |
DE2539730A1 (de) * | 1975-09-06 | 1977-03-17 | Bayer Ag | Mit carbonsaeureestergruppen modifizierte hydantoine |
FI71930C (fi) * | 1976-06-03 | 1987-03-09 | Wellcome Found | Foerfarande foer framstaellning av 1,5-disubstituerad hydantoin med aggregation av blodkroppar foerhindrande verkan. |
AU515174B2 (en) * | 1976-06-03 | 1981-03-19 | Wellcome Foundation Limited, The | Hydantoin derivatives |
IL53559A0 (en) * | 1976-12-18 | 1978-03-10 | Beecham Group Ltd | Novel prostaglandin analogues their preparation and pharmaceutical compositions containing them |
GB1598662A (en) * | 1976-12-18 | 1981-09-23 | Beecham Group Ltd | 10,12-diazoprostaglandins |
-
1978
- 1978-11-30 DK DK543178A patent/DK543178A/da not_active Application Discontinuation
- 1978-11-30 JP JP14855478A patent/JPS5492962A/ja active Pending
- 1978-11-30 ZA ZA786739A patent/ZA786739B/xx unknown
- 1978-11-30 AU AU42087/78A patent/AU531493B2/en not_active Expired
- 1978-12-01 DE DE7878101491T patent/DE2862445D1/de not_active Expired
- 1978-12-01 EP EP78101491A patent/EP0002259B1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
EP0002259A2 (en) | 1979-06-13 |
AU531493B2 (en) | 1983-08-25 |
AU4208778A (en) | 1979-06-07 |
DE2862445D1 (en) | 1984-11-08 |
EP0002259B1 (en) | 1984-10-03 |
EP0002259A3 (en) | 1979-06-27 |
DK543178A (da) | 1979-06-02 |
JPS5492962A (en) | 1979-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0003560A3 (en) | Imidazole derivatives and salts thereof, their synthesis, and intermediates, and pharmaceutical formulations | |
ZA786739B (en) | Hydantoin derivatives and salts thereof,their syntheses,and intermediates,and pharmaceutical formulations | |
DE2861237D1 (en) | Imidazole derivatives their synthesis and their pharmaceutical formulations | |
DE2862355D1 (en) | Amine derivatives, their preparation and pharmaceutical compositions containing them | |
IL55930A0 (en) | 1,9-dihydroxyoctahydrophenanthrenes, pharmaceutical compositions containing them and intermediates for their preparation | |
AU522796B2 (en) | Pharmaceutical preparations containing urea or hydantoin derivatives | |
DE2862419D1 (en) | Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates | |
EP0001647A3 (en) | Imidazoline derivatives and salts thereof, their synthesis, and intermediates, and pesticidal formulations | |
IL56064A (en) | L-and dl-phenylglycine amide derivatives,their preparation and pharmaceutical compositions containing them | |
NZ191100A (en) | Indanyl derivatives and herbicidal and pharmaceutical compositions intermediate | |
DE2861980D1 (en) | Phosphorus containing peptide derivatives, their production, intermediates for their production and pharmaceutical compositions containing them | |
ZA80996B (en) | Imidazole derivatives and salts thereof,their synthesis,and pharmaceutical formulations | |
DE2861638D1 (en) | Hydantoin derivatives and salts thereof, their synthesis and intermediates, and pharmaceutical formulations | |
EP0013315A3 (en) | Eburnane derivatives, including intermediates, their synthesis and pharmaceutical compositions containing them | |
NZ188946A (en) | 1,2-benzisoxazoloxyacetic acid derivatives pharmaceutical compositions | |
IL54689A (en) | Substituted phenylacetic acid amide derivatives,their preparation and pharmaceutical compositions containing them | |
GB2010813B (en) | Imidazole derivatives and salts thereof their synthesis and intermediates and pharmaceutical formulations | |
DE2860796D1 (en) | Tantomeric arylaminoimidazoline derivatives, their preparation and pharmaceutical formulations for analgetic application containing them | |
GB2008089B (en) | Imidazole derivatives and salts thereof their synthesis and intermediates and pharmaceutical formulations | |
IL54284A0 (en) | Non-glycosidic theophylline-sugar derivatives, their preparation and pharmaceutical compositions containing them | |
GB2006752B (en) | Imidazole derivatives and salts thereof their synthesis and intermediates and pharmaceutical formulations | |
DE2862424D1 (en) | Hydantoin derivatives, their synthesis, pharmaceutical formulations and intermediates in their preparation | |
IL56239A0 (en) | Pharmaceutical compositions comprising certain 1,3-bis-chromonyloxy-2-hydroxypropane derivatives | |
NZ192520A (en) | Hydantoin derivatives pharmaceutical compositions | |
IL55229A0 (en) | New oxanilic acid derivatives,their preparation and pharmaceutical compositions containing them |